Abbott Wins Defense Verdict In Biliary Stent Off-Label False Claim Trial

(April 8, 2016, 12:26 PM EDT) -- DALLAS — A Texas federal jury on April 7 returned a defense verdict in favor of Abbott Laboratories Inc. in a False Claims Act lawsuit in which the company was accused to off-label promotion of its biliary stents for use in the vascular system (United State of America, ex rel. Kevin Colquitt v. Abbott Laboratories, et al., No. 06-1769, N.D. Texas).

The verdict was rendered by a jury in the U.S. District Court for the Northern District of California on the same day the 12-day-long trial...
To view the full article, register now.